Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
02/2007
02/07/2007EP1749816A1 Production method of optically active diphenylalanine compounds
02/07/2007EP1749815A1 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
02/07/2007EP1749814A1 Iminocarboxylic acid salt-containing solid composition and production method thereof
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
02/07/2007CN1907955A Method of preparing potassium phenylaminoacetate in industrial scale from acrylonitrile apparatus by-product formonitrile
02/07/2007CN1907954A Water-soluble derivative of anesthetic 2,6-diisopropyl phenol and preparation method thereof
02/07/2007CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II
02/06/2007US7173154 Transfection reagents
02/06/2007US7173151 Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/01/2007WO2007013698A1 Process for production of mono-substituted alkylated compound using aldimine or derivative thereof
02/01/2007WO2007013689A1 Cyclopropanecarboxylic acid compound
02/01/2007US20070027216 Novel hydrochloride salts of levodopa
02/01/2007US20070027212 3-Aminomethyl-5-methyl-octanoic acid; antidepressant and anxiolytic agent; obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia; not addictive
02/01/2007US20070027210 trans-4-{[(2-methylpropanoyloxy)methoxycarbonyl]aminomethyl}-cyclohexanecarboxylic acid; reversibly blocks lysine binding sites on plasminogen and plasmin; stabilize fibrin clots, control excess bleeding; oral bioavailability
02/01/2007US20070027174 Phenylalanine Enamide Derivatives
02/01/2007US20070026478 Hemiasterlin affinity probes and their uses
01/2007
01/31/2007EP1747190A1 Process for the preparation of valsartan and precursors thereof
01/31/2007EP1747189A1 Preparation of levalbuterol hydrochloride
01/31/2007CN1906154A Aminoalcohol derivatives
01/31/2007CN1903835A Compound, composition and method for preventing neurodegeneration in acute and chronic injury of central nervous system
01/31/2007CN1903806A Method for preparing alkali metal salt and alkaline-earth metal salt of medicine
01/31/2007CN1903748A Iminocarboxylic acid salt-containing solid composition and production method thereof
01/30/2007US7169878 Diamines, polyimide precursors and polyimides produced by using the diamines, and liquid crystal aligning agents
01/30/2007US7169808 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
01/30/2007US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
01/30/2007US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus
01/30/2007US7169370 Method for co-precipitating actinides and method for preparing mixed actinide oxides
01/30/2007CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
01/30/2007CA2178879C Process for purifying valine
01/25/2007WO2007010387A2 Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
01/25/2007WO2007009944A1 Tritylation reactions based on metallic catalysis
01/25/2007WO2006133346A3 Ferric and acid complex
01/25/2007WO2006117696A3 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
01/25/2007WO2005118527A3 Fluorous capping reagents, and methods for peptide purification
01/25/2007US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
01/25/2007CA2616146A1 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field
01/25/2007CA2615978A1 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field
01/25/2007CA2615490A1 Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
01/24/2007EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound
01/24/2007EP1745012A2 Compositions of allosteric hemoglobin modifiers and methods of making the same
01/24/2007EP1744770A2 High yield and rapid syntheses methods for producing metallo-organic salts
01/24/2007EP1590317B1 ENANTIOMER-PURE (4S,8S)- AND (4R, 8R)-4-P-NITROBENZYL-8-METHYL-3, 6, 9-TRIAZA- SP 3 /sp N, SP 6 /SP N, SP 9 /SP N-TRICARBOXYMETHYL-1, 11-UNDECANOIC ACID AND DERIVATIVES THEREOF, METHOD FOR PRODUCING THEM, AND THEIR USE FOR PRODUCING PHARMACEUTICAL AGENTS
01/24/2007CN1902283A Reagent for detecting an analyte
01/24/2007CN1902158A N,N-dihalogenated amino acids and derivatives
01/24/2007CN1901879A Administration of levodopa and carbidopa
01/24/2007CN1900053A Process for preparing D-alpha-amino isovaleric acid
01/24/2007CN1900052A Method for preparing levo-serine and dextro serine by induced crystallizing method
01/24/2007CN1296345C Process for producing glycine
01/23/2007US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/23/2007US7166641 Diclofenac salt of lidocaine
01/23/2007US7166606 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa
01/23/2007CA2208495C The preparation of salts of pharmaceutical active substances which have acidic groups
01/23/2007CA2182987C Novel phosphoric acid-amino acid complex salt and additive composition containing the salt and used in feed for ruminant mammals
01/18/2007WO2007009055A2 Ester prodrugs of prostratin and related phorbol compounds
01/18/2007WO2007007791A1 Process and equipment for the decomposition and recovery of isocyanate compounds
01/18/2007US20070015932 Process for producing amino acid n-carboxyanhydride
01/18/2007US20070015930 Aqueous solution of a sodium salt of hedta
01/18/2007US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity
01/18/2007DE102005032307A1 Oligomere freier Fettsäuren und diese enthaltende Arzneimittel Oligomers of free fatty acids and pharmaceutical compositions containing them
01/17/2007EP1743899A1 Metal complexes for use in metathesis, atom transfer radical reactions, addition polymerisation and vinylation reactions, methods and intermediates for making them
01/17/2007EP1743015A1 Surfactant composition method for production thereof and cosmetic comprising said composition
01/17/2007EP1742906A2 Non-linear optically active molecules, their synthesis, and use
01/17/2007EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates
01/17/2007EP1742904A2 Substituted enaminones, their derivatives and uses thereof
01/17/2007CN1897911A Merocyanine derivatives for cosmetic use
01/17/2007CN1896070A 2- and 2,5-substituted phenylketo-enols
01/17/2007CN1896051A Production of monosodium glutamate solution by electrodialytic salt double decomposition
01/17/2007CN1896050A Production of gabapendin
01/17/2007CN1896049A Production of amino acetic acid
01/16/2007US7164049 Process for the preparation of 3,3-dimethylbutanal
01/16/2007US7164036 Colorant dispersibility, image lightfastness; storage stability
01/16/2007US7164034 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia
01/16/2007US7164027 Aralkyl ester soft drugs
01/16/2007US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders
01/11/2007WO2007004639A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ERYTHRO-β-AMINO ALCOHOL
01/11/2007WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
01/11/2007WO2007003486A1 Method for the production of quinazolinone derivatives
01/11/2007WO2006125030A3 Method for asymmetric alkynylation of alpha-imino esters
01/11/2007US20070010579 Copper salts of organic acids and use thereof as fungicides
01/11/2007US20070010453 Prodrugs of GABA analogs, compositions and uses thereof
01/11/2007CA2627590A1 Method for the production of quinazolinone derivatives
01/11/2007CA2613742A1 Novel derivatives of amino acids for treatment of obesity and related disorders
01/10/2007EP1741698A1 Method of separately collecting optically active amino acid amide and optically active amino acid
01/10/2007EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists
01/10/2007EP1153029B1 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
01/10/2007CN1894201A Di(L)-lysine monosulfate trihydrate crystal and method of making
01/10/2007CN1894173A Preparation of 18-fluoro-labeled aromatic amino acids
01/10/2007CN1891684A Method for preparing high-purity gahapentin
01/09/2007US7161029 Prepared by mixing a lysine-based solution with sulfuric acid at -10 to 35 degrees C., and allowing crystals to form that are characterized by having peaks at diffraction angles 2 theta of 16.6 degrees and 17.0 degrees as measured by powder X-ray diffraction
01/09/2007US7160870 Thrombopoietin mimetics
01/09/2007US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections
01/09/2007US7160507 Using a quaternary ammonium compound containing ether groups
01/09/2007CA2176788C Process for producing 4-trifluoromethylnicotinic acid
01/04/2007WO2007000994A1 Method of producing compound having anti-hcv action
01/04/2007US20070004889 Polymers based on n,n-diallylamine derivatives their production and use
01/04/2007US20070004803 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
01/04/2007US20070003788 Organic electroluminescence device
01/04/2007CA2612187A1 Stereoselective synthesis of amino acid analogs for tumor imaging
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 215